Be part of the knowledge.™

Oncology and Hematology

1890

LikeLikedUnlike

Episodes 1-15 of 260

Moving Forward–What Is on the Horizon? Personalized Therapies for Patients
MinuteCE®
Moving Forward–What Is on the Horizon? Personalized Therapies for Patients
- Jenny McDaniel, MD
  Peer
- Stephanie Ambrose, DO
  Peer
1.25 program credits
Evaluating Emerging Treatment Options: Rebalancing Therapies
MinuteCE®
Evaluating Emerging Treatment Options: Rebalancing Therapies
- Stephanie Ambrose, DO
  Peer
- Jenny McDaniel, MD
  Peer
1.25 program credits
Considering the Promise of New and Emerging Treatments for Hemophilia: Managing Thrombotic Risks
MinuteCE®
Considering the Promise of New and Emerging Treatments for Hemophilia: Managing Thrombotic Risks
- Jenny McDaniel, MD
  Peer
- Stephanie Ambrose, DO
  Peer
1.25 program credits
The Impact of Hemophilia Across Patients’ Lives
MinuteCE®
The Impact of Hemophilia Across Patients’ Lives
- Stephanie Ambrose, DO
  Peer
- Jenny McDaniel, MD
  Peer
1.25 program credits
Integrating New Therapies Into Healthcare
MinuteCE®
Integrating New Therapies Into Healthcare
- Stephanie Ambrose, DO
  Peer
- Jenny McDaniel, MD
  Peer
1.25 program credits
An Overview of Current and Emerging Treatment Options for Hemophilia A & B
MinuteCE®
An Overview of Current and Emerging Treatment Options for Hemophilia A & B
- Stephanie Ambrose, DO
  Peer
- Jenny McDaniel, MD
  Peer
1.25 program credits
Considering the Promise of New and Emerging Treatments for Hemophilia: The Need for ITI?
MinuteCE®
Considering the Promise of New and Emerging Treatments for Hemophilia: The Need for ITI?
- Stephanie Ambrose, DO
  Peer
- Jenny McDaniel, MD
  Peer
1.25 program credits
MinuteCE®
Advances in Hemophilia Treatment: Perspectives From Your Colleagues
- Stephanie Ambrose, DO
  Peer
- Jenny McDaniel, MD
  Peer
1.25 credits 10 episodes
Multidisciplinary Team Collaboration in the New Era of Hemophilia Treatment
MinuteCE®
Multidisciplinary Team Collaboration in the New Era of Hemophilia Treatment
- Jenny McDaniel, MD
  Peer
- Stephanie Ambrose, DO
  Peer
1.25 program credits
The Promise and Future of Gene Therapy
MinuteCE®
The Promise and Future of Gene Therapy
- Stephanie Ambrose, DO
  Peer
- Jenny McDaniel, MD
  Peer
1.25 program credits
Evaluating Novel Factor Replacement Strategies: Extended and Ultra-Half-Life Factors and Factor Mimetics
MinuteCE®
Evaluating Novel Factor Replacement Strategies: Extended and Ultra-Half-Life Factors and Factor Mimetics
- Jenny McDaniel, MD
  Peer
- Stephanie Ambrose, DO
  Peer
1.25 program credits
Enhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral Therapeutics
CME/CE
Enhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral Therapeutics
- Carlos M. de Castro, MD
  Peer
0.50 credits
Chairperson Perspective: Improving HR+/HER2- Breast Cancer Outcomes with TROP2 Antibody-Drug Conjugates
CME/CE
Chairperson Perspective: Improving HR+/HER2- Breast Cancer Outcomes with TROP2 Antibody-Drug Conjugates
- Aditya Bardia, MD, MPH
  Peer
0.25 credits
MinuteCE®
Chemotherapy Strategies in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
- Eileen O’Reilly, MD
  Peer
- Efrat Dotan, MD
  Peer
0.25 credits 2 episodes
HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
Project Oncology®
HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
- Fernando López-Ríos, MD, PhD
  Peer
- Christian Rolfo, MD, PhD
  Peer
- Charlie Gourley, MD, PhD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended